Management of twin pregnancies with fetal trisomies

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 2, 1997, Pages 220-222

  Sebire, Neil J ^a   Snijders, Rosalinde J M ^a   Santiago, Carlos ^a   Papapanagiotou, George ^a   Nicolaides, Kypros H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; FETUS; FETUS OUTCOME; HUMAN; LETHALITY; MEDICAL DECISION MAKING; PREGNANCY TERMINATION; PRIORITY JOURNAL; TRISOMY; TWIN PREGNANCY;

ABORTION, INDUCED; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; KARYOTYPING; PREGNANCY; PREGNANCY REDUCTION, MULTIFETAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRISOMY;

EID: 0031049501     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11049.x     Document Type: Article

References (8)

1. Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Br J Obstet Gynaecol 1996; 103: 999–1003.
2. Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH. Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency. Br J Obstet Gynaecol 1996; 103: 887–890.
3. Evans MI, Goldberg JD, Dommergues M et al. Efficacy of second-trimester selective termination for fetal abnormalities: international collaborative experience among the world’s largest centers. Am J Obstet Gynecol 1994; 171: 90–94.
4. Bass HN, Oliver JB, Srinivasan M. Persistently elevated AFP and AChE in amniotic fluid from a normal fetus following the demise of its twin. Prenat Diagn 1986; 6: 33–35.
5. Streit JA, Penick GD, Williamson RA, Weiner CP, Benda JA. Prolonged elevation of alphafetoprotein and detectable acetyl-cholinesterase after death of an anomalous twin fetus. Prenat Diagn 1989; 9: 1–6.
6. Grau P, Robinson L, Tabsh K, Crandall BF. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction. Obstet Gynecol 1990; 76: 1042–1045.
7. Abbas A, Johnson MR, Bersinger N, Nicolaides KH. Maternal serum alpha-fetoprotein in multifetal pregnancies before and after fetal reduction. Br J Obstet Gynaecol 1994; 101: 156–158.
8. Pandya PP, Snijders RJM, Johnson SJ, Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957–962.